UBS Group Increases Chemours (NYSE:CC) Price Target to $28.00

Chemours (NYSE:CC – Get Free Report) had its target price increased by research analysts at UBS Group from $21.00 to $28.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has a “neutral” rating on the specialty chemicals company’s stock. UBS Group’s price objective would suggest a potential upside of 1.38% from […]

Related Keywords

United States ,Blackrock ,Massachusetts ,America ,Asia Pacific ,Massachusetts Financial Services Co ,Barclays ,York Mellon Corp ,Chemours Company ,Blackrock Inc ,Specialized Solutions ,Vanguard Group Inc ,Get Free Report ,New York Mellon Corp ,Financial Services ,State Street Corp ,Street Corp ,North America ,Middle East ,Titanium Technologies ,Advanced Performance ,Chemours Daily ,